Israeli soccer club Maccabi Tel Aviv has been paired Pafos of Cyprus in the Champions League second qualifying round draw.

TuHURA Biosciences said its carcinoma therapy trials can continue now that health regulators have removed the partial clinical hold on the treatment tests.

cCentre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health ...

Actuate's Phase 2 trial shows elraglusib/GnP improves overall survival in mPDAC patients, with a 37% lower death risk. Actuate Therapeutics presented promising results from its Phase 2 trial ...

and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 VERITAC-2 clinical trial (NCT05654623 ...

President of Copper Peak Bob Jacquart said this first phase is focusing on the landing hill. “We’re going to redo the landing hill right now and get it, widen it, change the angle, and ...

More than a hundred power poles were toppled throughout the city. Austin Energy is in phase two of restoration, which are areas that affect most people. Phase one was public safety infrastructure.

The Baltimore Ravens held a tour of the stadium Thursday as phase two of renovations is currently underway. WATCH: Phase two of renovations underway at M&T Bank Stadium Phase two of renovations ...

Schottenheimer was asked about backup quarterback Joe Milton and whether he was in the "developmental phase." That led to Schottenheimer saying all of the quarterbacks can continue to learn ...

FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious ...

It is the largest phase three trial of an aldosterone synthase inhibitor for the treatment of hypertension. The results are a major milestone toward delivering the first targeted aldosterone ...